Table of Contents

June 01, 1991; Volume 39,Issue 6

You have access
Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents.
G Puia, S Vicini, P H Seeburg and E Costa

Molecular Pharmacology June 1991, 39 (6) 691-696;
You have access
Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide.
E Rubin, S Kharbanda, H Gunji and D Kufe

Molecular Pharmacology June 1991, 39 (6) 697-701;
You have access
Expression and characterization of the long and short splice variants of GS alpha in S49 cyc- cells.
J K O'Donnell, R W Sweet and J M Stadel

Molecular Pharmacology June 1991, 39 (6) 702-710;
You have access
Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.
M E Whalin, J G Scammell, S J Strada and W J Thompson

Molecular Pharmacology June 1991, 39 (6) 711-717;
You have access
Mechanism of antiviral and cytotoxic action of (+/-)-6' beta-fluoroaristeromycin, a potent inhibitor of S-adenosylhomocysteine hydrolase.
M Cools, J Balzarini and E De Clercq

Molecular Pharmacology June 1991, 39 (6) 718-724;
You have access
Central benzodiazepine receptors: in vitro efficacies and potencies of 3-substituted 1,4-benzodiazepine stereoisomers.
G Maksay, Z Tegyey and M Simonyi

Molecular Pharmacology June 1991, 39 (6) 725-732;
You have access
Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase.
K A Neve, B A Cox, R A Henningsen, A Spanoyannis and R L Neve

Molecular Pharmacology June 1991, 39 (6) 733-739;
You have access
Potent Gi-mediated inhibition of adenylyl cyclase by a phosphonate analog of monooleylphosphatidate.
M A Proll and R B Clark

Molecular Pharmacology June 1991, 39 (6) 740-744;
You have access
Role for ionotropic and metabotropic receptors in quisqualate-stimulated inositol polyphosphate accumulation in rat cerebral cortex.
J G Baird, R A Challiss and S R Nahorski

Molecular Pharmacology June 1991, 39 (6) 745-753;
You have access
Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
S T Safrany, R J Wojcikiewicz, J Strupish, J McBain, A M Cooke, B V Potter and S R Nahorski

Molecular Pharmacology June 1991, 39 (6) 754-761;
You have access
Calcium signaling and secretory responses in endothelin-stimulated anterior pituitary cells.
S S Stojilković, T Iida, F Merelli and K J Catt

Molecular Pharmacology June 1991, 39 (6) 762-770;
You have access
Kinetic analysis of ligand binding to the Ehrlich cell nucleoside transporter: pharmacological characterization of allosteric interactions with the [3H]nitrobenzylthioinosine binding site.
J R Hammond

Molecular Pharmacology June 1991, 39 (6) 771-779;
You have access
Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
L J Cornfield, G Lambert, L E Arvidsson, C Mellin, J Vallgårda, U Hacksell and D L Nelson

Molecular Pharmacology June 1991, 39 (6) 780-787;
You have access
Wheat germ agglutinin potentiates specific binding of platelet-activating factor to human platelet membranes and induces platelet-activating factor synthesis in intact platelets.
S B Hwang and S Wang

Molecular Pharmacology June 1991, 39 (6) 788-797;
You have access
Multiple affinity forms of the calcitonin gene-related peptide receptor in rat cerebellum.
T K Chatterjee and R A Fisher

Molecular Pharmacology June 1991, 39 (6) 798-804;
You have access
Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori

Molecular Pharmacology June 1991, 39 (6) 805-810;
You have access
Difference in the susceptibility of two phenobarbital-inducible forms, P450IIB1 and P450IIB2, to thyroid hormone- and growth hormone-induced suppression in rat liver: phenobarbital-inducible P450IIB2 suppression by thyroid hormone acting directly, but not through the pituitary system.
N Murayama, M Shimada, Y Yamazoe and R Kato

Molecular Pharmacology June 1991, 39 (6) 811-817;
You have access
Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
R W Jansen, G Molema, R Pauwels, D Schols, E De Clercq and D K Meijer

Molecular Pharmacology June 1991, 39 (6) 818-823;